Part, Chapter, Paragraph
1 III, 10. 2. 1 | Problem Drug Use~POU~Problem Opioid Use~REITOX~European Information
2 III, 10. 2. 1 | acquired/used prescription opioid medications). Other substances,
3 III, 10. 2. 1 | inhabitants aged 15–64.~ ~Problem opioid users and injecting drug
4 III, 10. 2. 1 | Drug Use estimates: Problem opioid use and injecting drug use~ ~
5 III, 10. 2. 1 | the prevalence of problem opioid users at national level
6 III, 10. 2. 1 | 1.3–1.7 million) problem opioid users in the EU and Norway.
7 III, 10. 2. 1 | be an increase in problem opioid use in some EU countries.
8 III, 10. 2. 1 | are predominantly problem opioid injectors, although they
9 III, 10. 2. 1 | an important increase in opioid, mainly heroin, and injecting
10 III, 10. 2. 1 | groups, including problem opioid users. These general trends
11 III, 10. 2. 1 | trend in the prevalence of opioid use is relatively stable,
12 III, 10. 2. 1 | or injecting of diverted opioid medications in several countries.
13 III, 10. 2. 1 | homogenous population of opioid users has been replaced
14 III, 10. 2. 1 | population including: ageing opioid users who also often use
15 III, 10. 2. 1(13)| them, HIV prevalence among opioid injectors was very high;
16 III, 10. 2. 1 | demanding treatment for opioid use has been falling until
17 III, 10. 2. 1 | estimated that at least 580 000 opioid users received drug substitution
18 III, 10. 2. 1 | at: htt ~ ~EMCDDA (2000): Opioid use and drug injection http ~ ~
19 Key, Ap5. 0. 0 | ophthalmologists~opiate~opioid~opioids~oral~organochlorine~
